Church & Dwight (CHD) 23rd annual dbAccess Global Consumer Conference summary
Event summary combining transcript, slides, and related documents.
23rd annual dbAccess Global Consumer Conference summary
2 Jun, 2026Business performance and growth strategy
Maintains a leading total shareholder return, with consistent organic growth averaging 4.1% over the past decade, even amid industry volatility in 2025 and a strong start in 2026.
Growth is driven by brand innovation, marketing, and successful acquisition and integration of high-margin, consumable brands.
Seven power brands account for over 75% of sales and profits, with a balanced portfolio split between household and personal care, and a mix of value and premium offerings.
Online sales have grown from 2% in 2016 to about 25%, reflecting agility and digital transformation, while low private label exposure enhances resilience.
Acquisitive strategy targets high-growth, high-margin brands, leveraging manufacturing and distribution strengths.
Acquisition and innovation updates
Recent acquisitions include Miss Mouth, a premium stain fighter brand with strong online presence and viral marketing, and Touchland, a leading premium hand sanitizer.
Miss Mouth is expanding from digital to brick-and-mortar, with rapid distribution gains at Walmart and Target, and plans for further expansion.
Innovation is a core growth driver, with about half of growth attributed to new products across personal care and household categories, and 1.5–2% incremental net sales from new launches.
New product launches include TheraBreath toothpaste, Hero invisible patch, Trojan G.O.A.T. condoms, and OxiClean innovations.
Power brands such as Arm & Hammer, TheraBreath, Hero, and Touchland are gaining share, with TheraBreath and Hero achieving all-time highs in 2025.
Strategic growth initiatives
Three main initiatives: grow Arm & Hammer from $2B to $3B, expand TheraBreath oral care from $1B to $1.5B, and double international business from $1B to $2B through M&A.
Arm & Hammer leverages high brand awareness and cross-category presence, with growth pillars in core innovation, category expansion, and licensing optimization.
TheraBreath focuses on increasing household penetration and expanding into toothpaste, leveraging strong mouthwash reputation and outpacing its category with 27.3% consumption growth.
International business targets high single-digit organic growth, rapid scaling of U.S. acquisitions, and increased focus on local consumer insights and regional innovation, especially in Asia.
Hero’s acne patch leads in six core markets and continues to expand globally.
Latest events from Church & Dwight
- Strong 2024 growth, innovation, and global expansion drive confidence in future performance.CHD
Consumer Analyst Group of New York Conference (CAGNY ) 20259 Jul 2026 - Q3 sales and margin gains offset by a $357.1M vitamin impairment; outlook remains positive.CHD
Q3 20249 Jul 2026 - 2025 targets 3–4% organic sales and 7–8% EPS growth, fueled by innovation and global expansion.CHD
Q4 2024 & Investor Day 20258 Jul 2026 - Focused on 4% organic growth, innovation, and M&A, with strong brands and expanding e-commerce.CHD
Barclays 17th Annual Global Consumer Staples Conference8 Jul 2026 - 2026 targets 3%-4% organic growth and 5%-8% EPS growth, led by Power Brands and innovation.CHD
Consumer Analyst Group of New York Conference (CAGNY) 20268 Jul 2026 - 2026 targets 3–4% organic sales growth, 5–8% EPS growth, and 100 bps margin expansion.CHD
Q4 2025 & Analyst Day 20268 Jul 2026 - Full-year outlook cut as sales and EPS fall, with strategic actions to reduce tariff risk by 80%.CHD
Q1 20258 Jul 2026 - Q1 2026 saw 5% organic growth, margin expansion, and EPS up 4.4%, with guidance reaffirmed.CHD
Q1 20265 May 2026 - Key votes include director elections, executive pay, auditor ratification, and a written consent proposal.CHD
Proxy filing19 Mar 2026